go-v.orgdoi

Lithium Treatment for ALS

Jang-Ho J. Cha · Journal watch · 2008

  • DOI 10.1056/jn200806100000003
  • Publisher Massachusetts Medical Society
  • Type article
  • Issued 2008

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Journal watch · Massachusetts Medical Society · article · 2008

Abstract

Amyotrophic lateral sclerosis (ALS) is an incurable degenerative disease. Riluzole can delay disease progression, but its efficacy is limited. Because of lithium’s neuroprotective effects in many animal models, these investigators explored lithium treatment for ALS in a two-part study. In a mouse model of ALS, lithium delayed disease progression and increased life span, compared with saline. Among other effects, lithium increased motor neuron survival, increased mitochondria in motor neurons, reduced necrosis, …

Open the resolved locator · 10.1056/jn200806100000003

Metadata licence: OpenAlex metadata (CC0)